The 2026 ASCO meeting has yielded key takeaways, with some outlets highlighting practice-changing progress and survival gains in certain types of cancer. The meeting reportedly covered various aspects of cancer research, including lymphoma, breast cancer, and non-small cell lung cancer. The takeaways from the meeting are expected to shape treatment and potentially redefine treatment standards in some areas of cancer care.